Tatalaksana Alopesia Androgenetik
DOI:
https://doi.org/10.55175/cdk.v45i8.735Keywords:
Alopesia androgenetik, folikel rambut, kelainan rambu, rambutAbstract
Rambut merupakan salah satu adneksa kulit yang terdapat di seluruh tubuh, kecuali telapak tangan, telapak kaki, kuku, dan bibir. Folikel rambut memiliki fase pertumbuhan dan fase istirahat yang bervariasi tergantung usia dan tempat tumbuh serta faktor fisiologis dan patologis. Alopesia androgenetik termasuk salah satu kelainan rambut yang disebabkan oleh faktor genetik dan hormon androgen ekstragonadal di kulit kepala. Alopesia androgenetik sering menyebabkan tekanan psikologis dan menurunnya kualitas hidup.
Hair is one of the adnexa of skin in all body parts except palm, soles, nails, and lip. Hair follicle undergoes growing phase and resting phase in variable periods of time depending on age, body site, physiological and pathological factors. Androgenetic alopecia is one of hair disorders caused by genetic factor and extragonadal androgenic hormone in the scalp. Androgenetic alopecia often causes significant psychological distress and reduction of quality of life.
Downloads
References
Hordinsky MK. Alopecia. In: Bologna JL, Jorizzo JL, Rapini RP, editors. Dermatology. 1st ed. Toronto: Mosby; 2003.p.1033-50.
Paus R, Olsen EA, Messenger AG. Hair growth disorders. In: Wolf K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw Hill; 2012.p.753-77
KaliyadanF, Nambiar A, Vijayaraghavan S. Androgenetic alopecia: An update. Indian J Dermatol Venerol Leprol. 2013;79(5):613-25
Soepardiman L. Kelainan rambut. In: Djuanda A, Hamzah M, Aisah S, editors. Ilmu penyakit kulit dan kelamin. 4th ed. Jakarta: FKUI; 2006 .p. 301-11
Tsuboi R, Itami S, Inui S, Ueki R, Katsuoka K, Kurata S. Guidelines for the androgenic alopecia. J Dermatol. 2012;39:113–20
Perez B. Ketoconazole as an adjunct to finasteride in the treatment of alopecia androgentic in men. Medical Hypotheses 2004;62:112–5
Sulling PL. Hair fall. Makalah dalam cosmetic dermatology update symposium. Jakarta: RSPAD; 2016.
Randall VA. Molecular basis of androgenetic alopecia. Springer-Verlag, Berlin Heidelberg; 2010. p. 9-19
Perera E, Sinclair R. Androgenetic alopecia. In: Sacchidanand S, Somiah S, editors. Scalp and its disorders. Melbourne: Jaypee Publ.; 2015.Ch.11.p.1-13
Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004;50(4):541-53. Epub 2004/03/23.
Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377-85.
Meidan VM, Touitou E. Treatments for androgenic alopecia and alopecia areata. Drugs 2001;61(1):53-69.
Alsantali A. Alopecia a new treatment plan. Clin Cosmet Investig Dermatol. 2011;4:107–15.
Nasution D. Penatalaksanaan kerontokan rambut secara topikal. In: Wasitatmadja SM, Menaldi SLS, Jacoeb TNA, Widowaty S, editors. Kesehatan dan keindahan rambut. 1st ed. Jakarta: Kelompok Studi Dermatologi Kosmetik Indonesia; 2002. p. 51-60
Avci P, Gupta GK, Clark J, Wikonkal N, Hamblin MR. Low-level laser (light) therapy (LLLT) for treatment of hair loss. Lasers Surg Med. 2014;46(2):144–51.
Kim SS, Park MW, Lee CJ. Phototherapy of androgenetic alopecia with low level narrow band 655-nm red light and 780-nm infrared light. J Am Acad Dermatol [Internet]. 2007. Available from: https://www.jaad.org/article/S0190-9622(06)03382-2/abstract
Satino JL, Markou M. Hair regrowth and increased hair tensile strength using the HairMax LaserComb for low-level laser therapy. Int J Cos Surg Aest Dermatol. 2003;5:113–7.
Leavitt M, Charles G, Heyman E, Michaels D. HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: A randomized, double- blind, sham device-controlled, multicentre trial. Clin Drug Investig. 2009;29(5):283–92
Dinh QQ, Sinclair R. Female pattern hair loss: Current treatment concepts. Clin Interventions in Aging. 2007;2(2):189-99.
Yeon JH, Jung JY, Choi JW, Kim BJ, Youn SW, Park KC, et al. 5 mg/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss. J Eur Acad Dermatol Venereol. 2011;25(2):211-4.
Thai KE, Sinclair RD. Finasteride for female androgenetic alopecia. Br J Dermatol. 2002;147(4):812- 3.
Handayani I. Pengobatan kerontokan rambut secara sistemik. In: Wasitaatmadja SM, Menaldi SLS, Jacoeb TNA, Widowaty S, editors. Kesehatan dan keindahan rambut. 1st ed. Jakarta: Kelompok Studi Dermatologi Kosmetik Indonesia; 2002. p. 39-50
Budisantoso G. Tindakan bedah pada kebotakan. In: Wasitaatmadja SM, Menaldi SLS, Jacoeb TNA, Widowaty S, editors. Kesehatan dan keindahan rambut. 1st ed. Jakarta: Kelompok Studi Dermatologi Kosmetik Indonesia; 2002. p. 51-60
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 https://creativecommons.org/licenses/by-nc/4.0/
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
